BOM:524164 (India)
Â
Shs Dematerialised
₹
401.30
(+1.4%)
Apr 24
Business Description
IOL Chemicals And Pharmaceuticals Ltd
NAICS : 325412
ISIN : INE485C01011
Share Class Description:
BOM:524164: Shs DematerialisedCompare
Compare
Traded in other countries / regions
IOLCP.India IPO Date
2001-10-25Description
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is manufacturing and sale of drugs and organic chemicals. The business activity is functioned through Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Chemical segment. Geographically, the group's products are sold in both Indian and international market.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.28 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.2 | |||||
| Interest Coverage | 18.53 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.48 | |||||
| Beneish M-Score | -2.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.7 | |||||
| 3-Year EBITDA Growth Rate | -25.9 | |||||
| 3-Year EPS without NRI Growth Rate | -27.9 | |||||
| 3-Year Book Growth Rate | 21.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.54 | |||||
| 9-Day RSI | 60.83 | |||||
| 14-Day RSI | 55.67 | |||||
| 6-1 Month Momentum % | -8.29 | |||||
| 12-1 Month Momentum % | -2.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.14 | |||||
| Quick Ratio | 1.4 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 81.57 | |||||
| Days Sales Outstanding | 81.74 | |||||
| Days Payable | 81.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.26 | |||||
| Dividend Payout Ratio | 0.14 | |||||
| 3-Year Dividend Growth Rate | 10.1 | |||||
| Forward Dividend Yield % | 1.26 | |||||
| 5-Year Yield-on-Cost % | 1.26 | |||||
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | 1.15 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.67 | |||||
| Operating Margin % | 9.93 | |||||
| Net Margin % | 7.8 | |||||
| FCF Margin % | -4.07 | |||||
| ROE % | 11.34 | |||||
| ROA % | 8.42 | |||||
| ROIC % | 9.89 | |||||
| ROC (Joel Greenblatt) % | 18.81 | |||||
| ROCE % | 15.48 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.38 | |||||
| PE Ratio without NRI | 13.36 | |||||
| Shiller PE Ratio | 14.18 | |||||
| Price-to-Owner-Earnings | 73.89 | |||||
| PEG Ratio | 2.34 | |||||
| PS Ratio | 1.05 | |||||
| PB Ratio | 1.44 | |||||
| Price-to-Tangible-Book | 1.49 | |||||
| Price-to-Operating-Cash-Flow | 18.77 | |||||
| EV-to-EBIT | 9.6 | |||||
| EV-to-EBITDA | 7.74 | |||||
| EV-to-Revenue | 1.06 | |||||
| EV-to-FCF | -25.03 | |||||
| Price-to-Projected-FCF | 0.78 | |||||
| Price-to-Median-PS-Value | 1.3 | |||||
| Price-to-Graham-Number | 0.95 | |||||
| Price-to-Net-Current-Asset-Value | 5.51 | |||||
| Earnings Yield (Greenblatt) % | 10.41 | |||||
| FCF Yield % | -3.81 | |||||
| Forward Rate of Return (Yacktman) % | 11.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
IOL Chemicals And Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 22,006.6 | ||
| EPS (TTM) (₹) | 29.22 | ||
| Beta | 0.95 | ||
| Volatility % | 51.24 | ||
| 14-Day RSI | 55.67 | ||
| 14-Day ATR (₹) | 13.926752 | ||
| 20-Day SMA (₹) | 386.715 | ||
| 12-1 Month Momentum % | -2.53 | ||
| 52-Week Range (₹) | 350.3 - 535.6 | ||
| Shares Outstanding (Mil) | 58.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
IOL Chemicals And Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
IOL Chemicals And Pharmaceuticals Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
IOL Chemicals And Pharmaceuticals Ltd Frequently Asked Questions
What is IOL Chemicals And Pharmaceuticals Ltd(BOM:524164)'s stock price today?
The current price of BOM:524164 is ₹401.30. The 52 week high of BOM:524164 is ₹535.60 and 52 week low is ₹350.30.
When is next earnings date of IOL Chemicals And Pharmaceuticals Ltd(BOM:524164)?
The next earnings date of IOL Chemicals And Pharmaceuticals Ltd(BOM:524164) is 2024-04-26 Est..
Does IOL Chemicals And Pharmaceuticals Ltd(BOM:524164) pay dividends? If so, how much?
The Dividend Yield %  of IOL Chemicals And Pharmaceuticals Ltd(BOM:524164) is 1.26% (As of Today), Highest Dividend Payout Ratio of IOL Chemicals And Pharmaceuticals Ltd(BOM:524164) was 0.2. The lowest was 0.05. And the median was 0.11. The  Forward Dividend Yield % of IOL Chemicals And Pharmaceuticals Ltd(BOM:524164) is 1.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers